Atrial Natriuretic Peptide (ANP), rat: Mechanisms & Research Use

Executive Summary: Atrial Natriuretic Peptide (ANP) is a 28-amino acid polypeptide hormone that regulates blood pressure and fluid balance by promoting natriuresis and vasodilation (product information). Its molecular formula is C49H84N20O15S, with a molecular weight of 1225.38 Da, and it is highly soluble in DMSO or water, but insoluble in ethanol. ANP is synthesized and secreted by atrial myocytes in response to atrial stretch and neurohumoral stimuli. APExBIO supplies this peptide (A1009) at ≥95.92% purity, validated by HPLC and mass spectrometry, facilitating high-reproducibility cardiovascular and homeostasis research (APExBIO). Studies indicate that peptide hormones such as ANP are critical tools for dissecting pathways in cardiovascular disease and adipose tissue metabolism (see advanced insights article).

Biological Rationale

Atrial Natriuretic Peptide (ANP) is endogenously produced and released by cardiac atrial myocytes in response to increased blood volume or pressure. Its primary function is to reduce systemic vascular resistance and promote sodium excretion. ANP acts as a counter-regulatory hormone opposing the effects of the renin-angiotensin-aldosterone system (RAAS), thereby maintaining cardiovascular and renal homeostasis (product specification). In rodent models, ANP is essential for experimental dissection of natriuretic, diuretic, and lipolytic responses. The peptide’s short half-life and rapid onset of action make it invaluable in acute and chronic studies of blood pressure regulation (integrative pathway article), extending previous reports by highlighting its cross-talk with adipose tissue metabolism under stress conditions.

Mechanism of Action of Atrial Natriuretic Peptide (ANP) (C49H84N20O15S), rat

ANP exerts its biological effects by binding to natriuretic peptide receptor-A (NPR-A), a guanylyl cyclase-linked receptor expressed in vascular smooth muscle, renal, and adipose tissues. Ligand-receptor engagement increases intracellular cyclic guanosine monophosphate (cGMP), triggering smooth muscle relaxation (vasodilation), enhanced glomerular filtration, and inhibition of sodium reabsorption in renal collecting ducts. This cascade results in reduced blood volume and pressure. ANP also promotes lipolysis by activating cGMP-dependent protein kinase in adipocytes (advanced insights article), clarifying the link between cardiovascular and metabolic regulation. The peptide’s rapid clearance via neutral endopeptidase and receptor-mediated uptake ensures tight physiological control.

Evidence & Benchmarks

• ANP is a 28-residue peptide hormone with the sequence H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-OH, and a molecular weight of 1225.38 Da (product details).
• Purity of APExBIO Atrial Natriuretic Peptide (A1009) is ≥95.92%, validated by HPLC and mass spectrometry (APExBIO).
• ANP is highly soluble in DMSO (≥122.5 mg/mL) and water (≥43.5 mg/mL), but insoluble in ethanol (product specification).
• ANP induces natriuresis and diuresis by increasing cGMP in renal tissues, reducing sodium reabsorption and promoting urine output (mechanistic review).
• Adiponectin, another peptide hormone, mitigates oxidative stress and neuroinflammation in aged rat models by suppressing the TLR4/MyD88/NF-κB pathway (DOI:10.21203/rs.3.rs-2117207/v1), providing a mechanistic parallel for peptide hormone research.
• ANP’s vasodilatory effects result in acute lowering of systemic blood pressure in rodent models (transforming cardiovascular research article).
• For optimal stability, ANP should be stored as a solid at -20°C and used promptly after reconstitution (supplier information).

Applications, Limits & Misconceptions

ANP is widely incorporated in cardiovascular disease research to model blood pressure regulation, fluid and electrolyte management, and adipose tissue metabolism. It enables both acute and chronic experimental designs in rats, such as hypertension, heart failure, and metabolic syndrome studies. The peptide’s high purity and consistent performance from APExBIO facilitate reproducible results across laboratories (see protocols guide). In contrast to the integrative pathways article, this dossier provides direct protocol parameters and solubility benchmarks for laboratory use.

Common Pitfalls or Misconceptions

• ANP is not stable in solution for extended storage; solutions should be used shortly after preparation (product info).
• It is ineffective for modeling chronic hypertension without repeated administration due to rapid plasma clearance.
• ANP is species-specific; rat peptide sequences may not recapitulate effects in human tissue without cross-validation.
• Not all vasodilators mimic ANP’s natriuretic and lipolytic effects, highlighting the need for mechanism-specific readouts (mechanistic review).
• Peptide hormone action is context-dependent; improper storage or buffer conditions can lead to rapid degradation and loss of activity.

Workflow Integration & Parameters

ANP is supplied as a lyophilized powder and should be equilibrated to room temperature before opening. Dissolve at concentrations ≥122.5 mg/mL in DMSO or ≥43.5 mg/mL in water. Ethanol is unsuitable for dissolution. For in vivo use, reconstitute in sterile saline or buffer immediately before administration. Shipping is on blue ice to maintain peptide integrity. ANP should be stored at -20°C in solid form; avoid repeated freeze-thaw cycles.

Protocol Parameters

• Solubilization: Dissolve at ≥122.5 mg/mL in DMSO or ≥43.5 mg/mL in water; do not use ethanol.
• Storage: Store solid peptide at -20°C; use reconstituted solutions immediately.
• Quality verification: Confirm ≥95.92% purity via HPLC/mass spectrometry before use in sensitive assays.
• Handling: Avoid multiple freeze-thaw cycles to maintain biochemical integrity.
• Application: For cardiovascular models, administer ANP acutely via intravenous or intraperitoneal injection to assess natriuretic and vasodilatory responses.

Conclusion & Outlook

Atrial Natriuretic Peptide (ANP), rat, remains a cornerstone for mechanistic studies in cardiovascular, renal, and adipose research. Its validated purity, solubility, and reproducibility support its continued use in benchmarking experiments and protocol optimization (APExBIO). The peptide’s actions are distinct from other hormone mediators, highlighting its unique value in dissecting natriuresis and blood pressure homeostasis. As demonstrated by parallel research on adiponectin’s effects in neuroinflammation (DOI referenced study), peptide hormones can provide mechanistic clarity for disease models. For further technical details on workflows and troubleshooting, consult the protocols guide—this article extends those recommendations by including updated product specifications and direct evidence citations.